Respiratory syncytial virus, or RSV, is a lung infection that’s highly contagious. But a vaccine recently approved by the FDA will soon be available for adults 60 or older. Here’s what to expect.
Related Posts
Solving problems is better than fearmongering
Windows adds support for RAR, Netflix cracks down on passwords, and Meta lays off workers
Startups should absolutely work with governments to support defense projects
3 Views on a16z’s latest reported early-stage effort
